These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24945464)

  • 21. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment strategies for microtubule stabilizing agent-resistant tumors.
    Broggini-Tenzer A; Sharma A; Nytko KJ; Bender S; Vuong V; Orlowski K; Hug D; O'Reilly T; Pruschy M
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25694444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.
    Juliachs M; Vidal A; Del Muro XG; Piulats JM; Condom E; Casanovas O; Graupera M; Germà JR; Villanueva A; Viñals F
    BMC Cancer; 2013 Aug; 13():382. PubMed ID: 23937707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A549-cells].
    Ling CH; Ji C; Chen YB; Fu JX; Zhou JY; Chen WC; Yang JC; Su LY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):683-6. PubMed ID: 16200871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
    Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
    Luo X; Slater JM; Gridley DS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Paesler J; Gehrke I; Gandhirajan RK; Filipovich A; Hertweck M; Erdfelder F; Uhrmacher S; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
    Clin Cancer Res; 2010 Jul; 16(13):3390-8. PubMed ID: 20570929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
    Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
    Mauceri HJ; Sutton HG; Darga TE; Kocherginsky M; Kochanski J; Weichselbaum RR; Vokes EE
    Oncol Rep; 2012 May; 27(5):1625-9. PubMed ID: 22294050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of radiotherapy combined with weekly recombinant human endostatin on the human pulmonary adenocarcinoma A549 xenografts in nude mice.
    Jiang XD; Dai P; Wu J; Song DA; Yu JM
    Lung Cancer; 2011 May; 72(2):165-71. PubMed ID: 20965604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
    Strawn LM; Kabbinavar F; Schwartz DP; Mann E; Shawver LK; Slamon DJ; Cherrington JM
    Clin Cancer Res; 2000 Jul; 6(7):2931-40. PubMed ID: 10914743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.
    Olaussen KA; Commo F; Tailler M; Lacroix L; Vitale I; Raza SQ; Richon C; Dessen P; Lazar V; Soria JC; Kroemer G
    Oncogene; 2009 Dec; 28(48):4249-60. PubMed ID: 19749798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D
    Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment.
    Paidi SK; Diaz PM; Dadgar S; Jenkins SV; Quick CM; Griffin RJ; Dings RPM; Rajaram N; Barman I
    Cancer Res; 2019 Apr; 79(8):2054-2064. PubMed ID: 30819665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.
    Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Singh SR; Kanaya F; Eilber FC; Hoffman RM
    Tissue Cell; 2018 Aug; 53():30-36. PubMed ID: 30060824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing Program.
    Keir ST; Morton CL; Wu J; Kurmasheva RT; Houghton PJ; Smith MA
    Pediatr Blood Cancer; 2012 Sep; 59(3):586-8. PubMed ID: 22190407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
    Tissue Cell; 2019 Jun; 58():107-111. PubMed ID: 31133237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.